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Abstract—The development of microarray-based high-
throughput gene profiling has led to the hope that this technol-
ogy could provide an efficient and accurate means of diagnos-
ing and classifying cancers. However, the large amount of data 
generated by microarrays requires effective selection of infor-
mative genes for cancer classification. Key issue that needs to 
be addressed is a selection of small number of informative 
genes that contribute to a disease from the thousands of genes 
measured on microarrays. This work deals with finding the 
small subset of informative genes from gene expression mi-
croarray data which maximize the classification accuracy. We 
introduce an improved version of hybrid of genetic algorithm 
and support vector machine for genes selection and classifica-
tion. We show that the classification accuracy of the proposed 
approach is superior to a number of current state-of-the-art 
methods of one widely used benchmark dataset. The informa-
tive genes from the best subset are validated and verified by 
comparing them with the biological results produced from 
biology and computer scientist researchers in order to explore 
the biological plausibility. 
Keywords—Gene selection; classification; genetic algorithm; 
support vector machine; gene expression; microar-
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I. INTRODUCTION  
Due to recent advances in biotechnology, gene expres-
sion can now be quantitatively monitored on a global scale. 
Gene expression data is created by a process known as mi-
croarray that yields a set of floating points and absolute 
values [1]. These values represent the activity level of each 
gene within an organism at a particular point of time and a 
typical dataset can often consist of thousands of genes [2]. 
Recent studies on molecular level classification of tissue 
have produced remarkable results and indicated that mi-
croarray gene expression could significantly aid in the de-
velopment of efficient cancer diagnosis [3,4]. However, 
classification based on the microarray data confronts with 
more challenges. One of the major challenges is the over-
whelming number of genes relative to the number of train-
ing samples in the datasets [2,4,5]. Most of the genes are not 
relevant to the distinction between different tissue types 
(classes) and introduce noise in the classification process, 
and thus potentially drown out the contribution of the rele-
vant ones [4]. 
In the gene expression domain, the gene refers to the fea-
ture. Feature selection or gene selection can be defined as a 
task for selecting subsets of features that maximizes the 
classifier ability to classify samples [6,7]. Gene selection 
methods can be classified into two categories. If gene selec-
tion is carried out independently from the classification 
procedure, the method is said to follow a filter approach. 
Otherwise, it is said to follow a wrapper (hybrid) approach 
[2,4]. Most of previous works used filter approach for se-
lecting genes since it was computationally more efficient 
than the hybrid approach [4,8]. The major drawback is that 
an optimal selection of genes may be independent from the 
inductive and representational biases of the learning algo-
rithm. Therefore, hybrid approach usually provide better 
accuracy but computationally more expensive than filter 
approach [4,9].
This research finds a small subset of informative genes 
from gene expression data which maximize the classifica-
tion accuracy in order to make a diagnosis far more likely to 
be widely deployed in a clinical. In this paper, we present an 
improved version of hybrid of genetic algorithm (GA) and 
support vector machine (SVM) classifier (GASVM-II) for 
genes selection and classification. 
In Section 2, we describe a hybrid of GA and SVM classi-
fier (GASVM) and introduce GASVM-II. In Section 3, we 
analyze the experimental results followed by conclusion in 
Section 4. 
II. A HYBRID OF GENETIC ALGORITHM AND SUPPORT  
VECTOR MACHINE CLASSIFIER (GASVM) 
The overall hybrid method consists of two main compo-
nents: GA [10] and SVM [11] classifier. The GA will select 
subsets of features and then the SVM classifier evaluates the 
subsets during a classification process. The result of the 
classification is used for the fitness value of GA. Fig. 1 
shows flow chart of GASVM. 
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Fig. 1 A flow chart of hybrid of GA and SVM classifier (GASVM). 
An individual represents a features subset (gene subset). 
The representation of chromosome (individual) used in 
GASVM appears in structural form as described in the pre-
vious works [2,9] and shown in Fig. 2. 
Fig. 2 A representation of chromosome in GASVM. 
Let n be the total number of features available for repre-
senting the data to be classified. Hence, the chromosome is 
represented by binary vector of dimension n. If a bit is 1, it 
means that the corresponding feature is selected. A value of 
0 indicates that the corresponding feature is not selected. 
The number of feature subsets based on the chromosome 
representation is calculated by using the following equation 
[10]. 
2nnc ?  (1) 
where nc  is the number of feature subsets, whereas n is the 
number of features. A fitness function of each individual is 
determined by evaluating the SVM using a training set. 
Hence, this research has used a fitness function containing 
classification accuracy as mentioned below. 
( ) ( )fitness x accuracy x?  (2) 
where accuracy(x) is the leave one out cross validation 
(LOOCV) accuracy of the classifier with the features subset 
selection represented by x.
GA is used to maximize the fitness value in order to find 
the optimal features subset which has achieved the highest 
LOOCV accuracy. Finally, it produced the optimal subset of 
training set. The optimal subset from training set is used to 
construct SVM. Therefore, it is used to test the performance 
of built SVM. 
A. An Improved Version of GASVM (GASVM-II) 
Since the data used in this work is high dimensional data, 
the conventional approaches are hard to be applied. Hence, 
we proposed an improved chromosome representation in 
order to overcome the limitation. We have modified the 
representation of chromosome in GASVM for selecting 
subset of features suitable to gene expression data. The 
modified GASVM is called GASVM-II. This idea is based 
on reducing the number of feature subsets from the Equa-
tion (1) by fixing the number of selected features leading to 
this equation. 
!
!( )!
n
x
nC
x n x
?
?
 (3) 
where n xC  is the total number of subsets of selected features 
x from the total of features n .
Fig. 3 An improved chromosome representation in GASVM-II 
Fig. 3 shows an improved chromosome representation in 
GASVM-II that based on Equation (3). It includes the real 
value fi in the chromosome which indicates a selected fea-
ture is the ith feature among total features in dataset. For 
example, if fi = 10, then the GASVM-II will select the 10th
feature in dataset in order to group it in related subset of 
features. The numbers of the real value fi are equal to the 
numbers of selected features before evaluation process. This 
structure is not much affected by the total number of fea-
tures and is able to represent chromosome in relatively 
small size. Its length can vary according to the size of the 
total number of features n and the number of selected fea-
tures. The length of the chromosome is the same in size for 
each chromosome. 
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The improved chromosome representation is developed 
to support more outstanding properties in genes selection 
for the cancer classification. The properties are as follows: 
? Reducing the number of gene subsets. 
? Supporting the high dimensional data. 
III. EXPERIMENTAL RESULTS
Several set of experiments were conducted to compare 
the results of the SVM, GASVM and GASVM-II. We used 
one gene expression dataset, i.e., leukemia cancer dataset 
[12]. A LOOCV procedure is employed on training data and 
accuracy test measurement on testing data to measure clas-
sification accuracy [9,12].  
A. Results Analysis and Discussions 
The experiments of GASVM-II were conducted by using 
10, 20, 30, 40, 50 and 60 genes in order to choose the best 
subset of genes among them. 
Table 1 displays all subsets of genes can achieve high 
LOOCV accuracy due to high correlation between samples 
in training set. However, results of Leukemia dataset on 
accuracy test are not uniform. The datasets properties, i.e., 
thousand of genes with less than hundred of samples in the 
training sets can be possibly cause the overfitting which 
learning a decision surface that performs well on the train-
ing data but bad on testing data. Furthermore, most of the 
genes are not relevant to the distinction between different 
tissue types (classes) and introduce noise in the classifica-
tion process, and thus potentially drowning out the contribu-
tion of the relevant ones. 
Table 1. Classification accuracies for different gene subsets in 
Leukemia Cancer dataset using GASVM-II method. 
Accuracy for Leukemia (%) Number of Selected 
Gene LOOCV Test 
10 100 79.4118 
20 100 76.4706 
30 100 94.1177 
40 100 97.0588 
50 100 94.1177 
60 100 88.2353 
Note:
The best result (subset of genes) shown in shaded cells
The selection of 40 genes from Leukemia Cancer dataset 
has achieved the best result at 100% using LOOCV proce-
dure while 97.0588% using accuracy test measurement. 
Hence, this subset will be chosen as the best subset. 
Table 2. Benchmark of GASVM-II and of previous methods on 
Leukemia Cancer dataset.
Accuracy (%) Method / Reference Number of Selected Genes LOOCV Test 
GASVM-II 40 100 97.0588 
GASVM 3568 94.7368 85.2941 
SVM 7129 94.7368 85.2941 
ART-NN [13] 10 100 97.0588 
LD [14] 50 100 97.0588 
MN [15] 10 100 90.0 
SVM [16] 49 100 100 
GAWV [9] 29 94.7368 88.2353 
WV [12] 50 94.7368 85.2941 
Note: 
Methods in boldface were experimented in this research. The best results shown in 
shaded cells. 
GASVM     : A Hybrid of GA and SVM 
GASVM-II : Proposed approach 
SVM          : Support vector machine classifier 
WV            : Weight voting classifier 
GAWV      : A Hybrid of GA and WV 
ART-NN    : Adaptive resonance theory neural network 
LD             : Logistic discriminant 
MN            : Modular neural network 
Based on the LOOCV and the accuracy test in Table 2, it 
was noted that GASVM-II performance was equal to meth-
ods produced by [13], and [14]. However, the ART-NN 
method proposed by [13] is the best method because it pro-
duced acceptable result with smaller number of genes (10 
genes) than other methods. Despite [16] achieved 100% 
accuracy by using 49 selected genes, but the result is not 
significant in this comparison because it rejected 4 samples 
when the confidence level procedure was introduced. Thus, 
the remaining of test samples only has 30 samples. The 
GASVM-II and several previous methods attained 100% 
accuracy using LOOCV procedure, but the previous re-
searches cannot attain the same results when using testing 
accuracy manner [13,14,15]. This is due to overfitting the 
data during the training phase when learning a decision 
surface in the classifiers performed well on the training data 
but not for testing data. GASVM-II can classify 33 out of 34 
test samples correctly. Among the sample, sample 66AML 
was consistently misclassified as AML. This AML sample 
was also misclassified by first original work [12] and other 
previous analyses [13,14]. 
All the previous works except [9] used filter approach for 
gene selection procedure. The filter approach is generally 
computationally more efficient than the hybrid approach. 
However, it was unable to avoid the noise and overfitting of 
the data because it is independent on classifier and depends 
on probabilistic distance measures, probabilistic dependence 
measures or interclass distance measures. Furthermore, the 
learning algorithm that has been used to construct the classi-
fier was bias. Hence, the gene selection methods based on 
the filter approach caused the methods to perform poorly on 
classification of the datasets. [9] applied the hybrid ap-
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proach using GAWV. However, they required recurring 
experiment of the hybrid method to achieve an optimal 
subset. Moreover, the result is still less than others because 
this method was used the chromosome representation which 
is only supporting the data ranged from small to medium 
features. 
As a result, when using the SVM classifier experimented 
in this research, the whole genes can contribute negative 
impact on classification performance because most of the 
genes in the data have many noises. GASVM method per-
forms poorly because the chromosome representation was 
unable to fix the selected genes and impossible to search all 
feature spaces and evaluate all possible gene subsets. The 
GASVM is unable to evaluate all subsets due to huge num-
ber of subsets. 
GASVM-II is able to avoid the noise problems because 
hybrid approach performs dependent on the classifier. The 
GASVM-II performs well in the experiment because it can 
fix the number of selected genes during gene selection and 
classification tasks. Hence, the GASVM-II reduces the 
complexity of search space and successfully evaluated all 
possible subsets of genes. It is shown that the selection of a 
small subset of informative genes using the GASVM-II can 
lead to significant improvement in classification accuracy 
for higher dimension data problems, i.e., gene expression 
data. 
B.  Biological Plausibility for Informative Genes in 
Leukemia Cancer Dataset 
Biological plausibility is one of the criteria for causality 
in epidemiology [17]. It is prominent in all aspects of health 
risk assessments. A major goal of diagnostic research is to 
develop diagnostic procedures based on the least possible 
genes to detect diseases [2,9].  
The best subset of 40 selected genes from Leukemia 
Cancer dataset was evaluated as the identical biological 
significant. These selected genes were evaluated by compar-
ing them with the results produced from biologist and com-
puter scientist researches. 
Table 3. List of the same informative genes in Leukemia Cancer
dataset produced by this research (GASVM-II) and previous works. 
Previous Work Gene Accession 
Number 
Informative Gene Description 
[18] M13690 C1NH Complement component 1 
inhibitor (angioedema, hereditary) 
[3,13] M55150 FAH Fumarylacetoacetate 
[3,12,18] M23197 CD33 antigen (differentiation 
antigen)
[3,18] Y07604 Nucleoside-diphosphate kinase 
Table 3 shows the lists of the similar informative genes 
of Leukemia Cancer dataset produced by GASVM-II and 
previous works. For instance, CD33 (M23197) were deter-
mined by [3,12,13], and [18]. CD33 is similarly a marker 
for AML, expressed in nearly all malignant myeloblasts 
[12].  
From the Table 3, some of the informative genes pro-
duced by GASVM-II were validated and verified as the 
identical biology significance. Much time will be saved in 
finding and validating the genes by using the proposed 
approach than traditional biopsy procedure. A number of the 
genes identified by the GASVM-II in these experiments are 
already in use as clinical markers for cancer diagnosis. 
Some of the remaining genes may be excellent candidates 
for further clinical investigation. Thus, the GASVM-II has 
the ability to find out the informative genes to be used by 
medical and health sectors. 
IV. CONCLUSION 
We have investigated and solved the important issues of 
selecting a small subset of informative genes from thou-
sands of gene measured on microarray that are inherently 
noisy. We have designed and developed the GASVM-II to 
select gene subsets for classification tasks. 
Our experiments have empirically evaluated SVM, 
GASVM and GASVM-II using Leukemia Cancer dataset. 
The GASVM-II performs very well in most experiments. 
We are currently studying more on principle design of fit-
ness using domain knowledge as well as mathematically 
well-founded tools. 
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